Research team led by BME's Cheng Zhu probes the underlying mechanisms of PD-1 checkpoint inhibitor therapy
Cheng Zhu leads study of immune system protein that helps control T cell activity
New research teases apart the mechanisms behind the checkpoint protein PD-1